KCM
GOSS icon

Kynam Capital Management’s Gossamer Bio GOSS Stock Holding History

Kynam Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-250,000
Closed -$208K – 26
2023
Q3 		$208K Buy
+250,000
New +$288K 0.03% 27
2023
Q2 		– Sell
-1,502,866
Closed -$1.89M – 29
2023
Q1 		$1.89M Sell
1,502,866
-268,679
-15% -$514K 0.24% 26
2022
Q4 		$3.84M Buy
1,771,545
+1,385,196
+359% +$11.4M 0.59% 22
2022
Q3 		$4.63M Sell
386,349
-1,964,099
-84% -$24.4M 0.98% 23
2022
Q2 		$19.7M Buy
2,350,448
+517,744
+28% +$4.01M 5.02% 7
2022
Q1 		$15.9M Buy
1,832,704
+815,847
+80% +$7.87M 5.16% 6
2021
Q4 		$11.5M Buy
+1,016,857
New +$12.1M 6.15% 4

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Kynam Capital Management's GOSS Position: Q4 2023 in Review

Kynam Capital Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 250,000 shares — an estimated $208K sold.

Kynam Capital Management first reported a position in GOSS in Q4 2021 and held it in 7 quarters. The position peaked at $19.7M in Q2 2022. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Kynam Capital Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Kynam Capital Management sold 250,000 Gossamer Bio shares in Q4 2023, an estimated $208K.
  • Kynam Capital Management first reported a position in Gossamer Bio in Q4 2021 and held it in 7 quarters.
  • Kynam Capital Management's Gossamer Bio position peaked at $19.7M in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Kynam Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.